Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05685485

Tied Tube Trial in Glaucoma Surgery

The Effects of Temporary Tube Ligation in Ahmed Glaucoma Valve Surgery

Status
Recruiting
Phase
Study type
Observational
Enrollment
152 (estimated)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.

Detailed description

The purpose of this study is to compare the post-operative surgical outcomes and complication rates in patients with different surgical techniques in the Ahmed FP7 glaucoma valve implant (New World Medical, Inc., Rancho Cucamonga, CA). In particular, the investigator wishes to assess whether delaying early aqueous flow by using a vicryl ligature (as done in most non-valved glaucoma drainage device implantation) will reduce the hypertensive phase, reduce early encapsulation, and optimize healing dynamics to allow for improved long term IOP results compared to standard implantation techniques. Aggressive early aqueous flow may introduce inflammatory mediators that may increase fibrosis during wound healing. Furthermore, mechanical compression of the tissue surrounding the plate may further lead to a denser capsule and limit aqueous diffusion through Tenon's and conjunctiva. For these reasons, the investigator postulate's that the limitation of early aqueous flow through the Ahmed valve will reduce the rates of hypertensive phase, lead to a thinner and less encapsulated bleb, reduce complication rates such as hypotony, and lead to overall improvement in long-term IOP reduction.

Conditions

Interventions

TypeNameDescription
PROCEDUREStandard ImplantationTraditional Ahmed plantation without vicryl ligature
PROCEDURETied off TubeAhmed implantation with vicryl ligature

Timeline

Start date
2022-10-18
Primary completion
2024-12-18
Completion
2025-01-31
First posted
2023-01-17
Last updated
2024-08-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05685485. Inclusion in this directory is not an endorsement.